CPS
TEVA icon

Counsel Portfolio Services’s Teva Pharmaceuticals TEVA Stock Holding History

Counsel Portfolio Services’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$5.29M Buy
105,290
+101,090
+2,407% +$5.38M 0.52% 61
2016
Q1 		$225K Hold
4,200
– – 0.03% 211
2015
Q4 		$276K Buy
+4,200
New +$260K 0.03% 231

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Counsel Portfolio Services's TEVA Position: Q2 2016 in Review

Counsel Portfolio Services increased its Teva Pharmaceuticals (TEVA) stake by 2,407% in Q2 2016, buying an estimated $5.38M and bringing the position to 105,290 shares worth $5.29M. The position accounts for 0.52% of the portfolio, ranked #61.

Counsel Portfolio Services first reported a position in TEVA in Q4 2015 and has held it in 3 quarters since. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

  • Counsel Portfolio Services held 105,290 shares of Teva Pharmaceuticals worth $5.29M as of Q2 2016.
  • Counsel Portfolio Services bought 101,090 Teva Pharmaceuticals shares in Q2 2016, an estimated $5.38M.
  • Teva Pharmaceuticals made up 0.52% of Counsel Portfolio Services's portfolio in Q2 2016, its #61 holding.
  • Counsel Portfolio Services first reported a position in Teva Pharmaceuticals in Q4 2015 and has held it in 3 quarters since.
  • 813 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Counsel Portfolio Services's 13F filing for Q2 2016, filed 12 Aug 2016.